ALVO News

Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®

Alvotech to present at upcoming investor conferences in June

Alvotech to present at upcoming investor conferences in June

Alvotech and Islandsbanki renew Market Making Agreement for ALVO Shares Trading on Nasdaq Iceland

Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility

Alvotech announces completion of FDA surveillance inspection at Reykjavik facility

Alvotech Q1 2026 Financial Results

Alvotech Q1 2026 Financial Results

Alvotech Announces a Change in its Executive Team

Alvotech Announces a Change in its Executive Team